Yasunori Kaneko's Net Worth

$261 Million

Who is Yasunori Kaneko?

Yasunori Kaneko has an estimated net worth of $261 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., RENOVIS INC, SI-BONE, Inc., SUTRO BIOPHARMA INC, Arcus Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, ACELRX PHARMACEUTICALS INC, COLLEGIUM PHARMACEUTICAL, INC, XENOPORT INC, HANSEN MEDICAL INC, and MERRILL CORP /NEW/ - FA.

SEC CIK

Yasunori Kaneko's CIK is 0001277503

Past Insider Trading and Trends

2014 was Yasunori Kaneko's most active year for acquiring shares with 14 total transactions. Yasunori Kaneko's most active month to acquire stocks was the month of January. 2014 was Yasunori Kaneko's most active year for disposing of shares, totalling 17 transactions. Yasunori Kaneko's most active month to dispose stocks was the month of January. 2011 saw Yasunori Kaneko paying a total of $6,179,715.00 for 4,090,244 shares, this is the most they've acquired in one year. In 2015 Yasunori Kaneko cashed out on 19,271,572 shares for a total of $976,582.64, their largest year based on trade value.